Language selection

Search

Details for: GRASTOFIL

Company: APOTEX INC

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
02441489GRASTOFILFILGRASTIM300 MCG / 0.5 MLSOLUTIONINTRAVENOUS
02441489GRASTOFILFILGRASTIM300 MCG / 0.5 MLSOLUTIONSUBCUTANEOUS
02454548GRASTOFILFILGRASTIM480 MCG / 0.8 MLSOLUTIONINTRAVENOUS
02454548GRASTOFILFILGRASTIM480 MCG / 0.8 MLSOLUTIONSUBCUTANEOUS
Search Reported Side Effects Report a Side Effect

Summary Reports

Summary Basis of Decision
Regulatory Decision Summary
Summary Safety Review - NEUPOGEN (filgrastim) and NEULASTA (pegfilgrastim) - Capillary Leak Syndrome

Consumer Information

The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.

Date modified: